0001562180-23-007805.txt : 20231120
0001562180-23-007805.hdr.sgml : 20231120
20231120184448
ACCESSION NUMBER: 0001562180-23-007805
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231116
FILED AS OF DATE: 20231120
DATE AS OF CHANGE: 20231120
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RECUPERO ANTHONY J
CENTRAL INDEX KEY: 0001210230
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38701
FILM NUMBER: 231424006
MAIL ADDRESS:
STREET 1: C/O SI-BONE, INC.
STREET 2: 471 EL CAMINO REAL, SUITE 101
CITY: SANTA CLARA
STATE: CA
ZIP: 95050
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SI-BONE, Inc.
CENTRAL INDEX KEY: 0001459839
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 262216351
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 471 EL CAMINO REAL, SUITE 101
CITY: SANTA CLARA
STATE: CA
ZIP: 95050
BUSINESS PHONE: 4082070700
MAIL ADDRESS:
STREET 1: 471 EL CAMINO REAL, SUITE 101
CITY: SANTA CLARA
STATE: CA
ZIP: 95050
FORMER COMPANY:
FORMER CONFORMED NAME: SI-Bone Inc.
DATE OF NAME CHANGE: 20090326
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0508
4
2023-11-16
false
0001459839
SI-BONE, Inc.
SIBN
0001210230
RECUPERO ANTHONY J
C/O SI-BONE, INC.
471 EL CAMINO REAL, SUITE 101
SANTA CLARA
CA
95050
false
true
false
false
President, Commercial Ops
true
Common Stock
2023-11-16
4
S
false
306.00
17.3809
D
208990.00
D
Common Stock
2023-11-16
4
S
false
1611.00
17.7327
D
207379.00
D
Common Stock
2023-11-16
4
S
false
1468.00
17.6856
D
205911.00
D
Common Stock
2023-11-16
4
S
false
2076.00
17.6943
D
203835.00
D
Common Stock
2023-11-17
4
S
false
2996.00
17.7818
D
200839.00
D
The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in
connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover"
transaction and does not represent a discretionary trade by the Reporting Person.
This transaction was executed in multiple trades at prices ranging from $17.11 USD to $17.605 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the
Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the
range set forth in this footnote.
This transaction was executed in multiple trades at prices ranging from $17.11 USD to $17.89 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the
Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the
range set forth in this footnote.
This transaction was executed in multiple trades at prices ranging from $17.11 USD to $17.87 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the
Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the
range set forth in this footnote.
This transaction was executed in multiple trades at prices ranging from $17.10 USD to $17.88 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the
Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the
range set forth in this footnote.
The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.
The shares were sold in multiple transactions ranging from $17.56 to $17.99 USD; the price reported above reflects the weighted average sale price.The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Includes 125,990 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit
represents a contingent right to receive one shares of the Issuer's common stock.
/s/ Michael A. Pisetsky, Attorney-in-Fact for Anthony J. Recupero
2023-11-20